---
id: eye-infections-keratitis-endophthalmitis_184
category: syndromes
tags: [eye-infections, keratitis, endophthalmitis, corneal-ulcer, intravitreal]
deck: Infectious Diseases
created: 2025-11-11
modified: 2025-11-11
---

## Eye Infections - Keratitis & Endophthalmitis

**Q:** What are the key features, organisms, and treatments for bacterial keratitis and endophthalmitis including intravitreal antibiotics?

**A:**

## BACTERIAL KERATITIS (CORNEAL ULCER)

**Mnemonic: "CONTACT-TRAUMA-PSEUDomonas-FLUOROQUINOLONE"**

### **DEFINITION:**
**Bacterial infection of cornea** → **corneal ulcer** (visible white/gray infiltrate with epithelial defect)

### **RISK FACTORS:**
- **Contact lens wear** (80% of cases - #1 risk factor)
- **Corneal trauma** (foreign body, abrasion)
- **Dry eye, blepharitis**
- **Immunosuppression** (diabetes, steroids)
- **Prior corneal surgery** (LASIK, cataract)

**Key Point:** **Contact lenses = #1 risk factor** (80% of bacterial keratitis)

---

### **ORGANISMS:**

**Mnemonic: "PSEUDO-STAPH-STREP-MORAX"**

**Contact Lens-Associated:**
1. ***Pseudomonas aeruginosa*** (40-50% - MOST COMMON in contact lens wearers)
   - **Rapid progression** (hours to days)
   - **Ring infiltrate** (characteristic)
   - **Can perforate** (medical emergency)

**Non-Contact Lens:**
2. ***Staphylococcus aureus*** (20-30%)
3. ***Streptococcus pneumoniae*** (10-15%)
4. **Moraxella** (5-10%)

**Key Point:** ***Pseudomonas* = most common** (contact lens - 40-50%) | **Rapid progression**

---

### **CLINICAL PRESENTATION:**

**Mnemonic: "PAIN-RED-PHOTOPHOBIA-DISCHARGE"**

**Symptoms:**
- **Severe eye pain** (worse than conjunctivitis)
- **Photophobia** (severe light sensitivity)
- **Foreign body sensation**
- **Blurred vision**
- **Purulent discharge**

**Signs:**
- **White/gray corneal infiltrate** (with epithelial defect)
- **Hypopyon** (layered white cells in anterior chamber - severe cases)
- **Conjunctival injection** (redness)

**Key Point:** **Corneal infiltrate + hypopyon** = severe keratitis (medical emergency)

---

### **TREATMENT:**

**Mnemonic: "FLUORO-FORTIFIED-NO-STEROIDS"**

**Empiric Therapy (Topical Fluoroquinolones):**
- **Moxifloxacin 0.5% OR ciprofloxacin 0.3% OR levofloxacin 0.5%** (topical drops)
- **Dosing:** **Q1H around the clock x 48 hours** (loading) → Q2-4H x 7-14 days

**Severe Cases (Fortified Antibiotics):**
- **Fortified vancomycin 25-50mg/mL** (for gram-positives) **+ fortified tobramycin 15mg/mL** (for gram-negatives including *Pseudomonas*)
- **Dosing:** **Q1H alternating** (vancomycin on the hour, tobramycin on the half-hour)

**AVOID Corticosteroids** (until infection controlled - delays healing, increases perforation risk)

**Key Point:** **Fluoroquinolone Q1H x 48 hours** (loading) | **NO steroids** until infection controlled

---

### **COMPLICATIONS:**

- **Corneal perforation** (especially *Pseudomonas* - hours to days)
- **Endophthalmitis** (extension to intraocular structures)
- **Corneal scarring** (permanent vision loss)

**Key Point:** ***Pseudomonas* = can perforate** (hours to days - medical emergency)

---

## ENDOPHTHALMITIS

**Mnemonic: "INTRAOCULAR-VITREOUS-INTRAVITREAL-ANTIBIOTICS"**

### **DEFINITION:**
**Infection of intraocular structures** (vitreous, aqueous) → **medical/surgical emergency**

### **CLASSIFICATION:**

**1. Post-Operative (Most Common - 70%):**
- **After cataract surgery** (most common - 0.1-0.3% of cataract surgeries)
- **After intravitreal injection** (anti-VEGF - 0.01-0.05%)
- **After glaucoma surgery, penetrating keratoplasty**

**2. Traumatic (10-20%):**
- **Open globe injury** (penetrating trauma)

**3. Endogenous (Hematogenous - 5-10%):**
- **Bacteremia/fungemia** → seeds eye (immunocompromised, IVDU, endocarditis)

**Key Point:** **Post-operative = most common** (70%) | **After cataract surgery** (0.1-0.3%)

---

### **ORGANISMS:**

**Post-Operative Endophthalmitis:**

**Mnemonic: "STAPH-EPIDERMIDIS-STREP-GRAM-NEG"**

1. ***Staphylococcus epidermidis*** (40-60% - MOST COMMON post-operative)
   - **Coagulase-negative Staph** (normal ocular flora)
2. ***Staphylococcus aureus*** (10-20%)
3. ***Streptococcus species*** (10-20%) - especially *S. pneumoniae*, *Streptococcus viridans*
4. **Gram-negatives** (5-10%) - *Pseudomonas, Klebsiella, Serratia*

**Endogenous Endophthalmitis:**

1. **Bacteria (70%):**
   - ***Staphylococcus aureus*** (30-40% - MOST COMMON)
   - ***Streptococcus species*** (20-30%)
   - ***Klebsiella pneumoniae*** (10-15% - liver abscess association)
   - ***Bacillus cereus*** (IVDU - rapid progression, poor prognosis)

2. **Fungi (30%):**
   - ***Candida albicans*** (70% of fungal - candidemia, IVDU, immunocompromised)
   - **Aspergillus** (immunocompromised)

**Key Point:** **Post-op = *S. epidermidis* (40-60%)** | **Endogenous = *S. aureus* (30-40%)**

---

### **CLINICAL PRESENTATION:**

**Mnemonic: "PAIN-VISION-LOSS-HYPOPYON"**

**Symptoms:**
- **Severe eye pain**
- **Acute vision loss** (hours to days)
- **Photophobia**
- **Floaters** (vitreous inflammation)

**Signs:**
- **Hypopyon** (layered white cells in anterior chamber - 70-80%)
- **Vitritis** (vitreous haze, loss of red reflex)
- **Conjunctival injection, lid edema**
- **Decreased visual acuity** (hand motion or worse - 50%)

**Timing:**
- **Acute (<6 weeks post-op):** 70% present within **7 days** of surgery
- **Chronic (>6 weeks post-op):** *Propionibacterium acnes*, coagulase-negative Staph

**Key Point:** **Acute vision loss + hypopyon + vitritis** = endophthalmitis (emergency)

---

### **TREATMENT:**

**Mnemonic: "TAP-INJECT-VANC-CEFTA-VITRECTOMY"**

### **IMMEDIATE (Within Hours):**

**1. Vitreous Tap + Intravitreal Antibiotics:**

**Vitreous Tap:** Obtain culture (0.1-0.3mL vitreous)

**Intravitreal Antibiotics (Inject Immediately):**
- **Vancomycin 1mg/0.1mL** (for gram-positives including MRSA)
- **PLUS**
- **Ceftazidime 2.25mg/0.1mL** (for gram-negatives including *Pseudomonas*)
  - **OR amikacin 0.4mg/0.1mL** (alternative gram-negative coverage)

**Fungal Endophthalmitis:**
- **Amphotericin B 5-10μg/0.1mL** OR **voriconazole 100μg/0.1mL** (intravitreal)

**Key Point:** **Intravitreal vancomycin + ceftazidime** (inject within hours)

---

**2. Systemic Antibiotics (Controversial):**

**Indication:** **Severe cases** (vision <hand motion, vitritis grade 3-4)

**Regimen:**
- **Vancomycin 15mg/kg IV Q12H** (for gram-positives)
- **PLUS**
- **Ceftazidime 2g IV Q8H** OR **cefepime 2g IV Q8H** (for gram-negatives)

**EVS Study:** Systemic antibiotics did NOT improve outcomes in post-operative endophthalmitis (intravitreal antibiotics sufficient)

**Key Point:** **Systemic antibiotics controversial** (EVS study: no benefit in post-op) | **Use if severe/endogenous**

---

**3. Vitrectomy:**

**Indication:**
- **Vision: Light perception only** (EVS study: vitrectomy superior to tap-inject)
- **No improvement after initial intravitreal antibiotics** (48 hours)
- **Retained lens material, foreign body**
- **Fungal endophthalmitis** (better source control)

**Not Indicated:**
- **Vision: Hand motion or better** (tap-inject equivalent to vitrectomy per EVS)

**Key Point:** **Vitrectomy if vision = light perception only** (EVS study) | **OR fungal**

---

**4. Corticosteroids (Adjunctive):**

**Intravitreal Dexamethasone 0.4mg/0.1mL:**
- **May reduce inflammation** (improves visual outcomes in some studies)
- **Controversial** (not in EVS protocol)

**Systemic Steroids:**
- **NOT routinely recommended** (no proven benefit, may worsen infection)

**Key Point:** **Intravitreal dexamethasone controversial** (may reduce inflammation)

---

### **ENDOPHTHALMITIS VITRECTOMY STUDY (EVS) - KEY FINDINGS:**

**Mnemonic: "VITRECTOMY-IF-LP-ONLY"**

**1. Vitrectomy vs Tap-Inject:**
- **Vision: Hand motion or better** → No difference (tap-inject equivalent)
- **Vision: Light perception only** → **Vitrectomy superior** (3x more likely to achieve ≥20/40 vision)

**2. Systemic Antibiotics:**
- **No benefit** when added to intravitreal antibiotics (post-operative endophthalmitis)

**Key Point:** **EVS: Vitrectomy if LP only** | **Systemic antibiotics = no benefit** (post-op)

---

### **PROGNOSIS:**

**Factors Predicting Poor Outcome:**
- **Initial vision: Light perception or worse** (50-70% remain <20/200)
- **Virulent organisms:** *Bacillus cereus, Pseudomonas, Streptococcus*
- **Delayed treatment** (>48 hours)

**Post-Operative Endophthalmitis:**
- **Final vision ≥20/40:** 50-70% (with prompt treatment)
- **Final vision <20/200:** 10-20%

**Endogenous Endophthalmitis:**
- **Worse prognosis** (final vision ≥20/40 in only 20-30%)

**Key Point:** **Prompt intravitreal antibiotics** = best outcomes (within hours)

---

**Clinical Pearls:**
- **Contact lenses = #1 risk factor** for bacterial keratitis (80%)
- ***Pseudomonas* = most common keratitis** (contact lens - 40-50%) | **Can perforate** (hours to days)
- **Fluoroquinolone Q1H x 48 hours** (keratitis loading) | **NO steroids** until controlled
- **Post-op endophthalmitis = *S. epidermidis* (40-60%)**
- **Endogenous endophthalmitis = *S. aureus* (30-40%)**
- **Acute vision loss + hypopyon + vitritis** = endophthalmitis (emergency)
- **Intravitreal vancomycin + ceftazidime** (inject within hours)
- **EVS: Vitrectomy if vision = LP only** | **Systemic antibiotics = no benefit** (post-op)
- **Fungal endophthalmitis = amphotericin OR voriconazole** (intravitreal) + vitrectomy
- **Prompt intravitreal antibiotics** = best outcomes (within hours)

**Media:**

**Additional Resources:**
- **EVS Study:** Endophthalmitis Vitrectomy Study
- **AAO Guidelines:** Bacterial keratitis and endophthalmitis
- **UpToDate:** Endophthalmitis

**Sources:** [EVS Study], [AAO Guidelines], [UpToDate Endophthalmitis]
